Most of the conversation around GLP-1 medications is about getting started and losing weight. Far less is said about the question that comes after: you've reached your goal — do you stop, stay on, or reduce? It's one of the most important decisions in the whole journey, and it deserves a clear-eyed answer.
Three paths after goal weight
Stop
Come off the medication entirely.
Stay
Continue at your current dose.
Reduce
Move to a lower maintenance dose.
There's no universal right answer — it depends on your health, your history, and a conversation with your provider. But the research does tell us some important things about what tends to happen with each.
What the research shows about stopping
This is the part many people don't hear until it's relevant: studies have consistently shown that stopping GLP-1 medication often leads to weight regain. In the well-known STEP-1 extension research on semaglutide, participants who stopped the medication regained a substantial portion of the weight they'd lost over the following year.
The reason is that these medications treat an ongoing biological process — they help regulate appetite and metabolism while you take them. Obesity is increasingly understood as a chronic condition, and like many chronic conditions, the underlying drivers don't disappear just because the numbers on the scale improved. That's not a reason you must stay on forever — but it's important to go in with realistic expectations rather than assuming the results hold automatically after stopping.
What "maintenance" actually means
Maintenance means using the medication — often at a reduced dose — to hold the results you've achieved rather than to keep losing. Many people and their providers find that a lower dose is enough to maintain, though this is individual. The goal shifts from "lose more" to "stay steady."
These get confused, but they're different ideas. Maintenance dosing is a clinical approach — a provider lowers your dose to hold results, based on your response. "Microdosing" is a trend term for using very low doses, often outside standard protocols, and it isn't an FDA-approved regimen. Some maintenance is done at lower doses, but not all "microdosing" is evidence-based maintenance. If you're thinking about a lower dose to maintain, that's a conversation for your provider — see our microdosing guide for the distinction.
How to think about your decision
- It's a medical decision, not a willpower test. Regain after stopping isn't a personal failure — it's the expected physiology. Frame the choice around health, not self-judgment.
- Talk to your provider before changing anything. Whether to stop, taper, or reduce should be guided by someone who knows your history — not decided alone or based on cost pressure.
- If you stop, have a plan. Some people do maintain with intensive lifestyle changes; going in with a structured plan gives you the best chance.
- Reduced-dose maintenance is a real option. For many, a lower ongoing dose is enough to hold results — worth discussing with your provider.
Ongoing GLP-1 management with a provider
Maintenance is individual — the right approach depends on your response and history. Provider-led telehealth programs can help you adjust to a maintenance dose and monitor how you hold your results over time.
Compare providers for ongoing care → Or read about lower-dose approaches →A licensed provider determines the right maintenance approach for you. This page is educational and not medical advice.
Common questions
Will I regain the weight if I stop?
Research shows weight regain is common after stopping GLP-1 medication, because it treats an ongoing process. Some people maintain with intensive lifestyle changes, but regain is the typical pattern. Discuss a plan with your provider.
Can I just lower my dose to maintain?
For many people, a reduced maintenance dose is enough to hold results — but it's individual and should be guided by your provider, not self-directed.
Is maintenance the same as microdosing?
Not necessarily. Maintenance is a clinical approach to holding results; "microdosing" is a trend term for very low doses often outside standard protocols. Some overlap exists, but they're not the same idea.
How long do people stay on for maintenance?
There's no fixed answer — obesity is often managed as a chronic condition, so some stay on long-term. This is a decision to make with your provider based on your health.